CardioMech AS is a biotechnology startup founded in 2015, based in Norway, that aims to address mitral regurgitation, the third most common cardiovascular disease. The market potential for its innovative device is projected to exceed the current $6 billion TAVR market. The CardioMech device is designed to offer a minimally invasive, catheter-based therapy as an alternative to open-heart surgery, potentially reducing the need for surgical intervention and watchful waiting. With its last investment of $13.00M in a Venture Round on 02 January 2024, CardioMech AS is poised to make strides in the medical device industry, offering a promising solution for patients with mitral regurgitation, a prevalent and life-threatening condition.
CardioMech AS
Founded 2015
Norway
9 employees
Venture round
Total: $54.72M
Biotechnology, Health Care +1
Norway
9 employees
Venture round
Total: $54.72M
Biotechnology, Health Care +1
General Information
Company Name
CardioMech AS
Founded Year
2015
Location
Norway
Norway
Employees
9
Industries
Biotechnology, Health Care, Medical Devices
Funding Stage
Venture round
Social
BounceWatch is an independent company data service, not affiliated with CardioMech AS. To contact CardioMech AS, visit cardiomech.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does CardioMech AS compare?
A PDF of CardioMech AS and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting CardioMech AS soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
From the desk
Is CardioMech AS on your competitive set?
Our desk can watch it and brief you on every move: hiring, funding, leadership, product and pricing.
Book a 7-day ReadoutDiscover More
Norway Market
Biotechnology
About CardioMech AS
Business keywords: mitral valve repair, catheter-based, cardiovascular treatment, artificial chord placement, innovative therapies, R&D development, FDA approval, regulatory compliance
Funding Rounds & Investors (6)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Venture Round | $13.00M | - |
|
02 Jan 2024 |
| Debt Financing | $4.53M | - |
|
16 Feb 2023 |
| Debt Financing | $6.17M | - |
|
29 Apr 2022 |
| Series A | $18.50M | 2 |
|
05 Aug 2020 |
| Convertible Note | $5.00M | - |
|
12 Aug 2019 |
| Debt Financing | $7.53M | - |
|
18 Feb 2019 |
CardioMech AS Alternatives & Competitors
View All Alternatives
CardioMech AS vs
Mitralign Inc.
United States
Mitralign, Inc. is the valve repair company with the only direct transcatheter annuloplasty system d...
Venture round
2 employees
Health Care, Medical Devices
CardioMech AS vs
NeoChord, Inc.
United States
Transforming Mitral Valve Repair
Convertible Note
20 employees
Biotechnology, Health Care
CardioMech AS vs
Designing the future of cardiac valve repair through innovative non-surgical solutions.
Series D
Health Care, Manufacturing
FAQ About CardioMech AS
Mitral Regurgitation is the third most common cardiovascular disease that occurs when there is backward flow of blood across the mitral valve. It is highly prevalent, debilitating for patients, and deadly if untreated. The market is expected to be larger than the TAVR market, currently a $6B market....
CardioMech AS was founded in 2015.
CardioMech AS is headquartered in Norway.
CardioMech AS operates in Biotechnology, Health Care and Medical Devices. Its work centres on mitral valve repair, catheter-based, cardiovascular treatment and artificial chord placement.
CardioMech AS has approximately 9 employees.
CardioMech AS has completed 6 funding rounds, raising a total of $54.72M. The latest funding stage is Venture round.
Top alternatives and competitors to CardioMech AS include Mitralign Inc., NeoChord, Inc., Evalve, Novostia, Affluent Medical. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
CardioMech AS and Mitralign Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.
Source: BounceWatch company record for CardioMech AS, https://bouncewatch.com/company/cardiomech-as, updated 20 December 2024. When citing, please name BounceWatch and link this page.
